Exelixis
EXEL
#1814
Rank
ยฃ8.32 B
Marketcap
ยฃ31.04
Share price
-1.36%
Change (1 day)
8.87%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total debt

Total debt on the balance sheet as of December 2025 : ยฃ0.13 Billion

According to Exelixis's latest financial reports the company's total debt is ยฃ0.13 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exelixis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2025-12-31ยฃ0.12 B-15.5%
2024-12-31ยฃ0.15 B1.99%
2023-12-31ยฃ0.14 B-5.15%
2022-12-31ยฃ0.15 B313.84%
2021-12-31ยฃ37.98 M5.48%
2020-12-31ยฃ36.01 M-1.64%
2019-12-31ยฃ36.61 M211.58%
2018-12-31ยฃ11.75 M6.31%
2017-12-31ยฃ11.05 M-92.79%
2016-12-31ยฃ0.15 B-45.65%
2015-12-31ยฃ0.28 B23%
2014-12-31ยฃ0.22 B8.92%
2013-12-31ยฃ0.21 B1.34%
2012-12-31ยฃ0.20 B77.87%
2011-12-31ยฃ0.11 B-13.52%
2010-12-31ยฃ0.13 B174.46%
2009-12-31ยฃ49.2 M-38.72%
2008-12-31ยฃ80.29 M31.27%
2007-12-31ยฃ61.16 M-1.52%
2006-12-31ยฃ62.1 M-28.05%
2005-12-31ยฃ86.31 M12.46%
2004-12-31ยฃ76.75 M23.6%
2003-12-31ยฃ62.09 M34.68%
2002-12-31ยฃ46.11 M36.6%
2001-12-31ยฃ33.75 M237%
2000-12-31ยฃ10.01 M21.69%
1999-12-31ยฃ8.23 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ36.05 B 27,600.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ45.77 B 35,064.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ41.06 B 31,446.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ19.20 B 14,654.74%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ31.12 B 23,810.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.46 B 27,141.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ17.95 B 13,690.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
ยฃ1.48 M-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ29.09 M-77.65%๐Ÿ‡บ๐Ÿ‡ธ USA